Silent myocardial ischemia: Diagnosis, treatment, and prognosis

Tera D. Moore; Amy P. Witte; Robert Chilton

Silent myocardial ischemia: Diagnosis, treatment, and prognosis

Tera D. Moore, Amy P. Witte, Robert Chilton

Medicine

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Silent myocardial ischemia is a major component of the total ischemic burden for patients with coronary artery disease (CAD); it is estimated that between 2 and 3 million persons with stable CAD have evidence of silent ischemia. Although statistically hard data are lacking on how treatment affects prognosis, management should aim to reduce or eliminate myocardial ischemia by risk factor modification, aggressive medical therapy and, if appropriate, myocardial revascularization.

Original language	English (US)
Journal	Consultant
Volume	49
Issue number	2
State	Published - Feb 1 2009

ASJC Scopus subject areas

Medicine(all)

Fingerprint Dive into the research topics of 'Silent myocardial ischemia: Diagnosis, treatment, and prognosis'. Together they form a unique fingerprint.

Cite this

@article{492136d0ac834e5ebd18a696fc6c1952,

title = "Silent myocardial ischemia: Diagnosis, treatment, and prognosis",

abstract = "Silent myocardial ischemia is a major component of the total ischemic burden for patients with coronary artery disease (CAD); it is estimated that between 2 and 3 million persons with stable CAD have evidence of silent ischemia. Although statistically hard data are lacking on how treatment affects prognosis, management should aim to reduce or eliminate myocardial ischemia by risk factor modification, aggressive medical therapy and, if appropriate, myocardial revascularization.",

author = "Moore, {Tera D.} and Witte, {Amy P.} and Robert Chilton",

year = "2009",

month = feb,

day = "1",

language = "English (US)",

volume = "49",

journal = "Consultant",

issn = "0010-7069",

publisher = "Cliggott Publishing Co.",

number = "2",

}

TY - JOUR

T1 - Silent myocardial ischemia

T2 - Diagnosis, treatment, and prognosis

AU - Moore, Tera D.

AU - Witte, Amy P.

AU - Chilton, Robert

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Silent myocardial ischemia is a major component of the total ischemic burden for patients with coronary artery disease (CAD); it is estimated that between 2 and 3 million persons with stable CAD have evidence of silent ischemia. Although statistically hard data are lacking on how treatment affects prognosis, management should aim to reduce or eliminate myocardial ischemia by risk factor modification, aggressive medical therapy and, if appropriate, myocardial revascularization.

AB - Silent myocardial ischemia is a major component of the total ischemic burden for patients with coronary artery disease (CAD); it is estimated that between 2 and 3 million persons with stable CAD have evidence of silent ischemia. Although statistically hard data are lacking on how treatment affects prognosis, management should aim to reduce or eliminate myocardial ischemia by risk factor modification, aggressive medical therapy and, if appropriate, myocardial revascularization.

UR - http://www.scopus.com/inward/record.url?scp=77953057208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953057208&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77953057208

VL - 49

JO - Consultant

JF - Consultant

SN - 0010-7069

IS - 2

ER -

Silent myocardial ischemia: Diagnosis, treatment, and prognosis

Abstract

ASJC Scopus subject areas

Other files and links

Cite this